Sort by

Send to

Choose Destination

Search results

Items: 2


Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.


Morphology and structure of the pollen cone and pollen grain of the Araucaria species from Argentina.

Del Fueyo GM, Caccavari MA, Dome EA.

Biocell. 2008 Apr;32(1):49-60.


Supplemental Content

Loading ...
Support Center